FCF Margin % is calculated as Free Cash Flow divided by its Revenue. T2 Biosystems's Free Cash Flow for the
three
months ended in Dec. 2023 was $-9.44 Mil. T2 Biosystems's Revenue for the
three
months ended in Dec. 2023 was $1.68 Mil. Therefore, T2 Biosystems's FCF Margin % for the quarter that ended in Dec. 2023 was -562.36%.
The historical rank and industry rank for T2 Biosystems's FCF Margin % or its related term are showing as below:
TTOO'
s FCF Margin % Range Over the Past 10 Years
Min: -25435.29 Med: -612.62 Max: -140.19
Current: -671.88
During the past 12 years, the highest FCF Margin % of T2 Biosystems was -140.19%. The lowest was -25435.29%. And the median was -612.62%.
TTOO's FCF Margin % is ranked worse than 91.07% of 224
companies
in the Medical Diagnostics & Research industry
Industry Median: -10.51
vs TTOO: -671.88
T2 Biosystems FCF Margin % Historical Data
The historical data trend for T2 Biosystems's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of T2 Biosystems's FCF Margin %
For the Diagnostics & Research subindustry, T2 Biosystems's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T2 Biosystems's FCF Margin % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's FCF Margin % distribution charts can be found below:
* The bar in red indicates where T2 Biosystems's FCF Margin % falls into.
T2 Biosystems FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
T2 Biosystems's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T2 Biosystems FCF Margin % Related Terms
Thank you for viewing the detailed overview of T2 Biosystems's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
T2 Biosystems (T2 Biosystems) Business Description
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TTOO has been successfully added to your 